Biocept reports 2021 fourth quarter and full year financial results

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and 12 months ended december 31, 2021 and provides a business update. “during the fourth quarter we expanded our cnside customer base to include several additional prestigious academic institutions while generating sequential-quarter volume growth,” said samuel d. riccitelli, biocept's chairman, and interim president and ceo.
BIOC Ratings Summary
BIOC Quant Ranking